People with obesity who take weight loss and diabetes drugs like Ozempic and Mounjaro could face a lower risk of cancer compared to those with obesity who do not. Looking at 14 cancers, of which 13 ...

New peptide drugs could take aim at a broader range of proteins that cause certain cancers, viral infections, and brain ...

Amylyx Pharmaceuticals, Inc. ((AMLX)) announced an update on their ongoing clinical study.Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing ...

After years of struggling with postpartum weight gain despite strict training and healthy eating, the 23-time Grand Slam ...

As cancer progression has been linked with high glucose, adiposity, insulin resistance, and systemic inflammation, investigators studied several glucose-lowering drugs in relationship to cancer ...

A new imaging approach reveals how dual agonist drugs like tirzepatide act on the pancreas and brain to regulate blood sugar and appetite.

If you have hypoglycemia during Ozempic treatment, it’s possible that once your blood sugar is stable, the blurred vision will clear. If it doesn’t clear or you have any other vision problems that ...

Serena Williams revealed how she turned her health around with the help of a GLP-1 medication after she struggled to lose ...

Serena Williams has revealed that she's taking a GLP-1 injectable weight loss treatment, in addition to her health regimen.

Glucagon-like peptide-1 (GLP-1) receptor agonists show promise in reducing cancer risk among patients with obesity, particularly for endometrial, ovarian, and meningioma cancers.

Tennis legend Serena Williams is sharing her journey with weight loss drugs, saying she's lost 31 pounds in 8 months using GLP-1s.

Discover a study exploring how GLP-1 receptor agonists may reduce symptoms of hidradenitis suppurativa through weight loss and anti-inflammatory effects.